Ockham’s Cicely Mitchell, principal biostatistician, authored an article featured in Statistics for Medicine titled “Discrete-time semi-Markov modeling of human papillomavirus persistence“

CARY, NC  — May 17, 2012 – Six internationally respected physicians and oncology researchers have been named to a new Scientific Advisory Board (SAB) formed by Ockham, the clinical research organization that acquired Scotland-based Nexus Oncology in January to broaden its international clinical impact. By engaging experts to assist with and review research, Ockham reaffirms [...]

Read about Ockham’s acquisition of Nexus Oncology published in Scottish newspaper ‘The Scotsman‘.

Ockham acquistion of Nexus Oncology featured in several online publications. (Click to link) FierceCRO Drug Discovery & Development Magazine Contract Pharma PharmaTimes Online Scotsman News & Observer

Cary, NC, February 13, 2012 – Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner. The combined company will operate under the name Ockham and will be led by Ockham’s [...]

Cary, NC, December 16, 2011 – Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, is pleased to announce the donation of $2,000 to the Ronald McDonald House on behalf of the fundraising efforts by the Cardinal Gibbons High School Cross Country team. The Ronald McDonald House program provides a [...]

Cary, NC, December 1, 2011 – Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, is pleased to announce for the second consecutive year they have been named to the Triangle Business Journal’s annual “Fast 50 Awards.” The annual listing names the 50 fastest growing private companies in the Triangle [...]

Cary, NC, October 6, 2011 – Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announced it has received the CEO Cancer Gold Standard Accreditation from the CEO Roundtable on Cancer, recognizing the company’s efforts to reduce cancer risks among employees and their families, while improving their overall health. [...]

For more than 20 years, October has been observed as National Breast Cancer Awareness Month. According to the United States Department of Health and Human Services, more than 230,000 women in the United States will be diagnosed with breast cancer and nearly 40,000 will die of the disease. In honor of this month, Ockham has changed [...]

Ockham Announces Appointment of Senior Director, Global Therapeutic Strategic Development to Ockham Oncology Cary, NC, August 8, 2011 – Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, is pleased to announce the appointment of Meghann Smith as Senior Director, Global Therapeutic Strategic Development within the Ockham CRO division effective [...]